iShares Neuroscience and Healthcare ETF (IBRN) is an ETF managed by BlackRock / iShares. Its largest position is BLACKROCK FUNDS III (BISXX), representing 8.57% of fund assets.
iShares Neuroscience and Healthcare ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- IBRN
- Type:
- ETF
- Manager:
- BlackRock / iShares
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 25, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
BLACKROCK FUNDS III
|
8.57% | $443,510.71 | 443,378 |
|
-
Xenon Pharmaceuticals Inc.
|
4.79% | $247,640.76 | 4,419 |
|
-
Axsome Therapeutics, Inc.
|
4.59% | $237,666.00 | 1,144 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
4.41% | $228,008.44 | 3,103 |
|
-
Alkermes plc.
|
4.20% | $217,294.66 | 6,446 |
|
-
CENTESSA PHARMACEUTICALS PLC
|
3.95% | $204,432.12 | 5,186 |
|
-
ARGENX SE
|
3.88% | $200,902.04 | 257 |
|
-
PTC THERAPEUTICS, INC.
|
3.69% | $191,146.28 | 2,938 |
|
-
NEUROCRINE BIOSCIENCES INC
|
3.68% | $190,658.16 | 1,448 |
|
-
BIOGEN INC.
|
3.67% | $190,037.12 | 1,004 |
|
-
Scholar Rock Holding Corp
|
3.67% | $189,935.75 | 4,075 |
|
-
Praxis Precision Medicines, Inc.
|
3.66% | $189,385.02 | 594 |
|
-
ACADIA PHARMACEUTICALS INC
|
3.61% | $186,963.60 | 8,328 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
3.39% | $175,424.40 | 1,998 |
|
-
CATALYST PHARMACEUTICALS INC
|
3.29% | $170,130.24 | 6,048 |
|
-
Denali Therapeutics Inc.
|
2.82% | $146,016.00 | 7,800 |
|
-
SUPERNUS PHARMACEUTICALS, INC.
|
2.78% | $144,000.00 | 3,000 |
|
-
Edgewise Therapeutics, Inc.
|
2.53% | $131,022.72 | 4,232 |
|
-
Dyne Therapeutics, Inc.
|
2.36% | $122,253.30 | 6,966 |
|
-
Axogen, Inc.
|
2.34% | $120,960.00 | 2,800 |
|
-
Sarepta Therapeutics, Inc.
|
2.21% | $114,422.40 | 5,480 |
|
-
SK BIOPHARMACEUTICALS CO LTD
|
2.04% | $105,633.78 | 1,547 |
|
-
APPLIED MATERIALS INC /DE
|
1.92% | $99,239.02 | 14,762 |
|
-
CAPRICOR THERAPEUTICS, INC.
|
1.75% | $90,430.94 | 2,693 |
|
-
Taysha Gene Therapies, Inc.
|
1.53% | $79,037.91 | 12,369 |
|
-
APPLIED MATERIALS INC /DE
|
1.37% | $71,053.46 | 2,026 |
|
-
Biohaven Ltd.
|
1.30% | $67,283.44 | 7,016 |
|
-
APPLIED MATERIALS INC /DE
|
1.06% | $54,701.61 | 6,016 |
|
-
Rapport Therapeutics, Inc.
|
1.03% | $53,339.30 | 1,610 |
|
-
APPLIED MATERIALS INC /DE
|
0.94% | $48,446.38 | 5,451 |
|
-
BRIGHT MINDS BIOSCIENCES INC.
|
0.92% | $47,405.05 | 539 |
|
-
APPLIED MATERIALS INC /DE
|
0.87% | $45,098.18 | 9,565 |
|
-
Annexon, Inc.
|
0.80% | $41,371.76 | 7,048 |
|
-
Alto Neuroscience, Inc.
|
0.78% | $40,311.86 | 1,571 |
|
-
APPLIED MATERIALS INC /DE
|
0.75% | $38,842.20 | 3,200 |
|
-
INTEGRA LIFESCIENCES HOLDINGS CORP
|
0.75% | $38,734.50 | 3,675 |
|
-
APPLIED MATERIALS INC /DE
|
0.65% | $33,455.35 | 1,155 |
|
-
LB PHARMACEUTICALS INC
|
0.63% | $32,851.56 | 1,036 |
|
-
Brainsway Ltd.
|
0.60% | $30,950.64 | 1,869 |
|
-
Ceribell, Inc.
|
0.52% | $26,953.92 | 1,337 |
|
-
PROTHENA CORP PUBLIC LTD CO
|
0.51% | $26,455.52 | 2,392 |
|
-
APPLIED MATERIALS INC /DE
|
0.51% | $26,359.40 | 9,000 |
|
-
ONCOLYS BIOPHARMA INC
|
0.49% | $25,401.94 | 1,400 |
|
-
RELMADA THERAPEUTICS, INC.
|
0.48% | $25,071.68 | 3,334 |
|
-
Solid Biosciences Inc.
|
0.46% | $23,972.52 | 3,302 |
|
-
APPLIED MATERIALS INC /DE
|
0.46% | $23,964.57 | 18,000 |
|
-
Design Therapeutics, Inc.
|
0.46% | $23,718.40 | 1,744 |
|
-
NeuroPace Inc
|
0.46% | $23,570.28 | 1,398 |
|
-
REGENXBIO Inc.
|
0.44% | $22,712.04 | 2,532 |
|
-
Benitec Biopharma Inc.
|
0.42% | $21,665.90 | 1,798 |
Advertisement (320x50)